IOBT icon

IO Biotech
IOBT

Overview Fund Activity

26 hedge funds and large institutions have $18.1M invested in IO Biotech in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
+7
Holders Change %
+36.84%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
1
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DIG
1
Dauntless Investment Group
New Hampshire
$688K
2
LCM
2
Landscape Capital Management
New Jersey
$407K
3
Citadel Advisors
3
Citadel Advisors
Florida
$249K
4
SAM
4
Sectoral Asset Management
Quebec, Canada
$69K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$55K

Top Sellers

1
SB
1
Samsara BioCapital
California
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$790K
3
LGM
3
Logos Global Management
California
$0
4
UBS Group
4
UBS Group
Switzerland
$43.3K
5
Two Sigma Investments
5
Two Sigma Investments
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$5 5 +5 New
SB
27
Samsara BioCapital
California
– – -3,640,015 Closed
LGM
28
Logos Global Management
California
– – -493,827 Closed
Two Sigma Investments
29
Two Sigma Investments
New York
– – -30,000 Closed
VF
30
Virtu Financial
New York
– – -17,954 Closed
Osaic Holdings
31
Osaic Holdings
Arizona
– – -230 Closed
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
1
2